220 related articles for article (PubMed ID: 17150260)
1. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
Larsen BT; Campbell WB; Gutterman DD
Trends Pharmacol Sci; 2007 Jan; 28(1):32-8. PubMed ID: 17150260
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of epoxyeicosatrienoic acids in coronary vascular function.
Larsen BT; Gutterman DD; Hatoum OA
Eur J Clin Invest; 2006 May; 36(5):293-300. PubMed ID: 16634832
[TBL] [Abstract][Full Text] [Related]
4. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.
Gauthier KM; Yang W; Gross GJ; Campbell WB
J Cardiovasc Pharmacol; 2007 Dec; 50(6):601-8. PubMed ID: 18091575
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
6. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA; Fang X; Snyder GD; Weintraub NL
Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
[TBL] [Abstract][Full Text] [Related]
8. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
9. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
Zordoky BN; El-Kadi AO
Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acids, cell signaling and angiogenesis.
Fleming I
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):60-7. PubMed ID: 17164133
[TBL] [Abstract][Full Text] [Related]
12. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
13. Vascular pharmacology of epoxyeicosatrienoic acids.
Pfister SL; Gauthier KM; Campbell WB
Adv Pharmacol; 2010; 60():27-59. PubMed ID: 21081214
[TBL] [Abstract][Full Text] [Related]
14. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
Fleming I
Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived epoxyeicosatrienoic acids and vascular function.
Fleming I; Busse R
Hypertension; 2006 Apr; 47(4):629-33. PubMed ID: 16490839
[TBL] [Abstract][Full Text] [Related]
16. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.
Ni GH; Chen JF; Chen XP; Yang TL
Pharmazie; 2011 Mar; 66(3):153-7. PubMed ID: 21553642
[TBL] [Abstract][Full Text] [Related]
18. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
Karkhanis A; Tram NDT; Chan ECY
Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
[TBL] [Abstract][Full Text] [Related]
19. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
20. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.
Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I
Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]